Controlled Clinical TrialtaVNSn = 61

Participant-centered tolerability of transcutaneous auricular vagus nerve stimulation: insights from two crossover studies

Gonzalez G, O’Malley M, Bolanos J, Taylor D, McTeague LM, Canepa A, Wong ML

Bioelectronic Medicine · 2026

Key finding

Across two crossover studies, taVNS was well tolerated with mild, transient sensations at the ear and high participant acceptability, supporting its suitability for repeated non-invasive use.

Condition
Safety
Stimulation
taVNS
Evidence tier
Controlled Clinical Trial
Participants
61
View on DOI

Cite this study

Gonzalez, G., O’Malley, M., Bolanos, J., Taylor, D., McTeague, L. M., Canepa, A., & Wong, M. L. (2026). Participant-centered tolerability of transcutaneous auricular vagus nerve stimulation: insights from two crossover studies. Bioelectronic Medicine, 12(1). https://doi.org/10.1186/s42234-026-00206-y

Related studies in Safety

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.